MGMT and brain neoplasm: In addition to identifying mutations correlated with specific subclonal expansions, we also examined the expression of O6-methylguanine DNA methyltransferase (MGMT), which is known to drive brain tumor recurrence through increased expression in post-temozolomide lesions (Bocangel et al. 2002; Hegi et al. 2005).